Dyslipidemia in Type 2 Diabetes (0767-034)

NCT00547274 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II
Dyslipidemia

Interventions

DRUG: MK0767

Sponsor

Merck Sharp & Dohme LLC